TriLink BioTechnologies opens new mRNA manufacturing facility

TriLink BioTechnologies today announced it opened its new cGMP mRNA manufacturing facility.

The new 32,000 sq. ft. facility, based in San Diego, is specifically designed for mRNA manufacturing. Using the company’s mRNA manufacturing capabilities, it will support late-phase drug developers from Phase 2 to commercialization. TriLink said the opening is expected to help advance the field of mRNA-based medicine.

TriLink’s new facility has individual Grade C cleanroom suites for mRNA manufacturing, increased mRNA capacity, comprehensive in-house analytical services and laboratory space for on-site quality control testing. The manufacturing site is also outfitted with “state-of-the-art” equipment and is ready to onboard clients with late-phase manufacturing needs.

“This facility is expected to help move the needle for life-saving breakthroughs in mRNA therapeutics,” Kevin Lynch, VP and GM of TriLink’s GMP operations, said in a new…

Read more
  • 0